Catechins and its role in chronic diseases

Advances in Experimental Medicine and Biology

Volumn 929, Issue , 2016, Pages 67-90

  Shirakami, Yohei ^a   Sakai, Hiroyasu ^a   Kochi, Takahiro ^a   Seishima, Mitsuru ^a   Shimizu, Masahito ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Cancer; Cardiovascular disease; Catechin; Chemoprevention; Green tea; Metabolic syndrome; Neurodegenerative disease; Obesity

Indexed keywords

CATECHIN; CATECHIN GALLATE; CYCLOOXYGENASE 2; EPICATECHIN DIGALLATE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIGALLOCATECHIN DIGALLATE; EPIGALLOCATECHIN GALLATE; GALLOCATECHIN GALLATE; POLYPHENOL; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT; NEUROPROTECTIVE AGENT; PLANT EXTRACT; TEA;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; DEGENERATIVE DISEASE; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; METABOLIC SYNDROME X; MOLECULAR MECHANICS; MOUSE; NEOPLASM; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RISK FACTOR; TEA; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DISEASE MODEL; DRUG DEVELOPMENT; DRUG EFFECTS; ISOLATION AND PURIFICATION; MEDICINAL PLANT; PHYTOTHERAPY; PROCEDURES; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARDIOVASCULAR AGENTS; CATECHIN; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; HUMANS; MOLECULAR STRUCTURE; NEUROPROTECTIVE AGENTS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TEA;

EID: 84992445352     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-41342-6_4     Document Type: Chapter

References (150)

1. Cabrera C, Gimenez R, Lopez MC (2003) Determination of tea components with antioxidant activity. J Agric Food Chem 51(15):4427-4435. doi:10.1021/jf0300801
2. Basu A, Lucas EA (2007) Mechanisms and effects of green tea on cardiovascular health. Nutr Rev 65(8 Pt 1):361-375
3. Wang S, Noh SK, Koo SI (2006) Green tea catechins inhibit pancreatic phospholipase A(2) and intestinal absorption of lipids in ovariectomized rats. J Nutr Biochem 17(7):492-498. doi:10.1016/j.jnutbio.2006.03.004
4. Chen Z, Zhu QY, Tsang D, Huang Y (2001) Degradation of green tea catechins in tea drinks. J Agric Food Chem 49(1):477-482
5. Majumder K, Mine Y, Wu J (2015) The potential of food-protein derived anti-inflammatory peptides against various chronic inflammatory diseases. J Sci Food Agric. doi:10.1002/jsfa.7600
6. Zhang YJ, Gan RY, Li S, Zhou Y, Li AN, Xu DP, Li HB (2015) Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules 20 (12):21138-21156. doi:10.3390/molecules201219753
7. Yang CS, Wang ZY (1993) Tea and cancer. J Natl Cancer Inst 85(13):1038-1049
8. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H (2006) Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 66(5):2500-2505. doi:10.1158/0008-5472.CAN-05-3636
9. Chiu FL, Lin JK (2005) HPLC analysis of naturally occurring methylated catechins, 3’ ‘-and 4’ ‘-methyl-epigallocatechin gallate, in various fresh tea leaves and commercial teas and their potent inhibitory effects on inducible nitric oxide synthase in macrophages. J Agric Food Chem 53(18):7035-7042. doi:10.1021/jf0507442
10. Mukhtar H, Ahmad N (1999) Green tea in chemoprevention of cancer. Toxicol Sci Official J Soc Toxicol 52(2 Suppl):111-117
11. Zaveri NT (2006) Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci 78(18):2073-2080. doi:10.1016/j.lfs.2005.12.006
12. Zheng LT, Ryu GM, Kwon BM, Lee WH, Suk K (2008) Anti-inflammatory effects of catechols in lipopolysaccharide-stimulated microglia cells: inhibition of microglial neurotoxicity. Eur J Pharmacol 588(1):106-113. doi:10.1016/j.ejphar.2008.04.035
13. Lambert JD, Elias RJ (2010) The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys 501(1):65-72. doi:10.1016/j.abb.2010.06.013
14. Mukhtar H, Ahmad N (2000) Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 71(6 Suppl):1698S-1702S; discussion 1703S-1694S
15. Shimizu M, Shirakami Y, Moriwaki H (2008) Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG. Int J Mol Sci 9(6):1034-1049. doi:10.3390/ijms9061034
16. Tachibana H (2009) Molecular basis for cancer chemoprevention by green tea polyphenol EGCG. Forum Nutr 61:156-169. doi:10.1159/000212748000212748[pii]
17. Chedea VS, Braicu C, Chirila F, Ogola HJ, Pelmus RS, Calin LG, Socaciu C (2014) Antioxidant/prooxidant and antibacterial/probacterial effects of a grape seed extract in complex with lipoxygenase. BioMed Res Int 2014:313684. doi:10.1155/2014/313684
18. Groeger G, Quiney C, Cotter TG (2009) Hydrogen peroxide as a cell-survival signaling molecule. Antioxid Redox Sig 11(11):2655-2671. doi:10.1089/ARS.2009.2728
19. Oliveira-Marques V, Marinho HS, Cyrne L, Antunes F (2009) Role of hydrogen peroxide in NF-kappaB activation: from inducer to modulator. Antioxid Redox Sig 11(9):2223-2243. doi:10.1089/ARS.2009.2601
20. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44-84. doi:10.1016/j.biocel.2006.07.001
21. Youn HS, Lee JY, Saitoh SI, Miyake K, Kang KW, Choi YJ, Hwang DH (2006) Suppression of MyD88-and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem Pharmacol 72 (7):850-859. doi:10.1016/j.bcp.2006.06.021
22. Nakagawa K, Okuda S, Miyazawa T (1997) Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci Biotechnol Biochem 61(12):1981-1985
23. Ullmann U, Haller J, Decourt JP, Girault N, Girault J, Richard-Caudron AS, Pineau B, Weber P (2003) A single ascending dose study of epigallocatechin gallate in healthy volunteers. J Int Med Res 31(2):88-101
24. Van het Hof KH, Wiseman SA, Yang CS, Tijburg LB (1999) Plasma and lipoprotein levels of tea catechins following repeated tea consumption. In: Proceedings of the society for experimental biology and medicine society for experimental biology and medicine, vol 220, no 4, pp 203-209
25. Chow HH, Cai Y, Hakim IA, Crowell JA, Shahi F, Brooks CA, Dorr RT, Hara Y, Alberts DS (2003) Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 9(9):3312-3319
26. Surh YJ (2003) Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3 (10):768-780
27. Hanausek M, Walaszek Z, Slaga TJ (2003) Detoxifying cancer causing agents to prevent cancer. Integr Cancer Ther 2(2):139-144. doi:10.1177/1534735403002002005
28. Shimizu M, Weinstein IB (2005) Modulation of signal transduction by tea catechins and related phytochemicals. Mutat Res 591(1-2):147-160
29. Wang J, Eltoum IE, Lamartiniere CA (2004) Genistein alters growth factor signaling in transgenic prostate model (TRAMP). Mol Cell Endocrinol 219(1-2):171-180. doi:10.1016/j.mce.2003.12.018
30. Masuda M, Suzui M, Lim JT, Deguchi A, Soh JW, Weinstein IB (2002) Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol 2(6):350-359
31. Masuda M, Suzui M, Lim JT, Weinstein IB (2003) Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res 9(9):3486-3491
32. Masuda M, Suzui M, Weinstein IB (2001) Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 7(12):4220-4229
33. Shimizu M, Deguchi A, Hara Y, Moriwaki H, Weinstein IB (2005) EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Biochem Biophys Res Commun 334(3):947-953
34. Shimizu M, Deguchi A, Joe AK, McKoy JF, Moriwaki H, Weinstein IB (2005) EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J Exp Ther Oncol 5(1):69-78
35. Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L, Weinstein IB (2005) (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res 11(7):2735-2746
36. Yang CS, Maliakal P, Meng X (2002) Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42:25-54
37. Shankar S, Ganapathy S, Hingorani SR, Srivastava RK (2008) EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci J Virtual Libr 13:440-452
38. Barthelman M, Bair WB III, Stickland KK, Chen W, Timmermann BN, Valcic S, Dong Z, Bowden GT (1998) (-)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity. Carcinogenesis 19(12):2201-2204
39. Gupta S, Ahmad N, Nieminen AL, Mukhtar H (2000) Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol 164(1):82-90. doi:10.1006/taap.1999.8885
40. Shankar S, Suthakar G, Srivastava RK (2007) Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer. Front Biosci J Virtual Libr 12:5039-5051
41. Fujiki H, Suganuma M, Okabe S, Sueoka N, Komori A, Sueoka E, Kozu T, Tada Y, Suga K, Imai K, Nakachi K (1998) Cancer inhibition by green tea. Mutat Res 402(1-2):307-310
42. Shimizu M, Shirakami Y, Sakai H, Adachi S, Hata K, Hirose Y, Tsurumi H, Tanaka T, Moriwaki H (2008) (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice. Cancer Prev Res (Phila) 1(4):298-304. doi:10.1158/1940-6207.CAPR-08-00451/4/298[pii]
43. Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23(1A):363-398
44. Hussain T, Gupta S, Adhami VM, Mukhtar H (2005) Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer (Journal international du cancer) 113 (4):660-669. doi:10.1002/ijc.20629
45. Kundu JK, Na HK, Chun KS, Kim YK, Lee SJ, Lee SS, Lee OS, Sim YC, Surh YJ (2003) Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells. J Nutr 133(11 Suppl 1):3805S-3810S
46. Peng G, Wargovich MJ, Dixon DA (2006) Anti-proliferative effects of green tea polyphenol EGCG on Ha-Ras-induced transformation of intestinal epithelial cells. Cancer Lett 238 (2):260-270. doi:10.1016/j.canlet.2005.07.018S0304-3835(05)00666-X[pii]
47. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H (1997) Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 89(24):1881-1886
48. Okabe S, Fujimoto N, Sueoka N, Suganuma M, Fujiki H (2001) Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array. Biol Pharm Bull 24(8):883-886
49. Gupta S, Hastak K, Afaq F, Ahmad N, Mukhtar H (2004) Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene 23(14):2507-2522. doi:10.1038/sj.onc.1207353
50. Cai Y, Yu SS, Chen TT, Gao S, Geng B, Yu Y, Ye JT, Liu PQ (2013) EGCG inhibits CTGF expression via blocking NF-kappaB activation in cardiac fibroblast. Phytomedicine Int J Phytotherapy Phytopharmacology 20(2):106-113. doi:10.1016/j.phymed.2012.10.002
51. Lemmon MA, Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141 (7):1117-1134. doi:10.1016/j.cell.2010.06.011S0092-8674(10)00665-3[pii]
52. Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell 103(2):211-225. doi:10.1016/S0092-8674(00)00114-8[pii]
53. Hynes NE, Lane HA (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5(5):341-354. doi:10.1038/nrc1609nrc1609[pii]
54. Pollak MN, Schernhammer ES, Hankinson SE (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer 4(7):505-518. doi:10.1038/nrc1387nrc1387[pii]
55. Ellis LM, Hicklin DJ (2008) VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer 8(8):579-591. doi:10.1038/nrc2403nrc2403[pii]
56. Pianetti S, Guo S, Kavanagh KT, Sonenshein GE (2002) Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res 62(3):652-655
57. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H (2001) Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci U S A 98(18):10350-10355. doi:10.1073/pnas.171326098
58. Adhami VM, Siddiqui IA, Ahmad N, Gupta S, Mukhtar H (2004) Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res 64(23):8715-8722. doi:10.1158/0008-5472.CAN-04-284064/23/8715[pii]
59. Shimizu M, Shirakami Y, Sakai H, Tatebe H, Nakagawa T, Hara Y, Weinstein IB, Moriwaki H (2008) EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells. Cancer Lett 262(1):10-18
60. Shimizu M, Shirakami Y, Sakai H, Yasuda Y, Kubota M, Adachi S, Tsurumi H, Hara Y, Moriwaki H (2010) (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells. Chem Biol Inter 185(3):247-252. doi:10.1016/j.cbi.2010.03.036S0009-2797(10)00199-7[pii]
61. Shirakami Y, Shimizu M, Adachi S, Sakai H, Nakagawa T, Yasuda Y, Tsurumi H, Hara Y, Moriwaki H (2009) (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis. Cancer Sci 100(10):1957-1962. doi:10.1111/j.1349-7006.2009.01241.xCAS1241[pii]
62. Lee YK, Bone ND, Strege AK, Shanafelt TD, Jelinek DF (2003) Kay NE (2004) VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood 104 (3):788-794. doi:10.1182/blood-2003-08-276308-2763[pii]
63. Umeda D, Yano S, Yamada K, Tachibana H (2008) Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor. J Biol Chem 283(6):3050-3058. doi:10.1074/jbc.M707892200M707892200[pii]
64. Adachi S, Nagao T, Ingolfsson HI, Maxfield FR, Andersen OS, Kopelovich L, Weinstein IB (2007) The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer Res 67(13):6493-6501. doi:10.1158/0008-5472.CAN-07-041167/13/6493[pii]
65. Adachi S, Nagao T, To S, Joe AK, Shimizu M, Matsushima-Nishiwaki R, Kozawa O, Moriwaki H, Maxfield FR, Weinstein IB (2008) (-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells. Carcinogenesis 29(10):1986-1993. doi:10.1093/carcin/bgn128bgn128[pii]
66. Adachi S, Shimizu M, Shirakami Y, Yamauchi J, Natsume H, Matsushima-Nishiwaki R, To S, Weinstein IB, Moriwaki H, Kozawa O (2009) (-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser 1046/1047 by p38 MAPK in colon cancer cells. Carcinogenesis 30(9):1544-1552. doi:10.1093/carcin/bgp166bgp166[pii]
67. Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, Bapat P, Kwun I, Shen CL (2014) Novel insights of dietary polyphenols and obesity. J Nutr Biochem 25(1):1-18. doi:10.1016/j.jnutbio.2013.09.001
68. Chan CY, Wei L, Castro-Munozledo F, Koo WL (2011) (-)-Epigallocatechin-3-gallate blocks 3T3-L1 adipose conversion by inhibition of cell proliferation and suppression of adipose phenotype expression. Life Sci 89(21-22):779-785. doi:10.1016/j.lfs.2011.09.006
69. Lee MS, Kim Y (2009) (-)-Epigallocatechin-3-gallate enhances uncoupling protein 2 gene expression in 3T3-L1 adipocytes. Biosci Biotechnol Biochem 73(2):434-436. doi:10.1271/bbb.80563
70. Rice-Evans C (1999) Implications of the mechanisms of action of tea polyphenols as antioxidants in vitro for chemoprevention in humans. In: Proceedings of the society for experimental biology and medicine society for experimental biology and medicine, vol 220, no 4, pp 262-266
71. Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS (2008) The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 138(9):1677-1683
72. Ortsater H, Grankvist N, Wolfram S, Kuehn N, Sjoholm A (2012) Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice. Nutr Metab 9:11. doi:10.1186/1743-7075-9-11
73. Snoussi C, Ducroc R, Hamdaoui MH, Dhaouadi K, Abaidi H, Cluzeaud F, Nazaret C, Le Gall M, Bado A (2014) Green tea decoction improves glucose tolerance and reduces weight gain of rats fed normal and high-fat diet. J Nutr Biochem 25(5):557-564. doi:10.1016/j.jnutbio.2014.01.006
74. Ahmad RS, Butt MS, Sultan MT, Mushtaq Z, Ahmad S, Dewanjee S, De Feo V, Zia-Ul-Haq M (2015) Preventive role of green tea catechins from obesity and related disorders especially hypercholesterolemia and hyperglycemia. J Transl Med 13:79. doi:10.1186/s12967-015-0436-x
75. Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici A, Kim JA, Quon MJ, Montagnani M (2007) EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292(5):E1378-E1387. doi:10.1152/ajpendo.00698.2006
76. Shirakami Y, Shimizu M, Moriwaki H (2012) Cancer chemoprevention with green tea catechins: from bench to bed. Curr Drug Targets 13(14):1842-1857
77. Yang CS, Wang H, Li GX, Yang Z, Guan F, Jin H (2011) Cancer prevention by tea: evidence from laboratory studies. Pharmacol Res 64(2):113-122. doi:10.1016/j.phrs.2011.03.001
78. Li N, Chen X, Liao J, Yang G, Wang S, Josephson Y, Han C, Chen J, Huang MT, Yang CS (2002) Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 23(8):1307-1313
79. Wang ZY, Wang LD, Lee MJ, Ho CT, Huang MT, Conney AH, Yang CS (1995) Inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats by green and black tea. Carcinogenesis 16(9):2143-2148
80. Yamane T, Takahashi T, Kuwata K, Oya K, Inagake M, Kitao Y, Suganuma M, Fujiki H (1995) Inhibition of N-methyl-N’-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach. Cancer Res 55(10):2081-2084
81. Ju J, Hong J, Zhou JN, Pan Z, Bose M, Liao J, Yang GY, Liu YY, Hou Z, Lin Y, Ma J, Shih WJ, Carothers AM, Yang CS (2005) Inhibition of intestinal tumorigenesis in Apcmin/ + mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res 65 (22):10623-10631. doi:10.1158/0008-5472.CAN-05-194965/22/10623[pii]
82. Shirakami Y, Shimizu M, Tsurumi H, Hara Y, Tanaka T, Moriwaki H (2008) EGCG and Polyphenon E attenuate inflammation-related mouse colon carcinogenesis induced by AOM plus DDS. Mol Med Rep 1:355-361
83. Kochi T, Shimizu M, Shirakami Y, Yoshimi K, Kuramoto T, Tanaka T, Moriwaki H (2015) Utility of Apc-mutant rats with a colitis-associated colon carcinogenesis model for chemoprevention studies. Eur J Cancer Prev Official J Eur Cancer Prev Organ 24(3):180-187. doi:10.1097/CEJ.0000000000000063
84. Ishino K, Mutoh M, Totsuka Y, Nakagama H (2013) Metabolic syndrome: a novel high-risk state for colorectal cancer. Cancer Lett 334(1):56-61. doi:10.1016/j.canlet.2012.10.012
85. Jinjuvadia R, Patel S, Liangpunsakul S (2014) The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis. J Clin Gastroenterol 48 (2):172-177. doi:10.1097/MCG.0b013e3182a030c4
86. Shimizu M, Sakai H, Shirakami Y, Yasuda Y, Kubota M, Terakura D, Baba A, Ohno T, Hara Y, Tanaka T, Moriwaki H (2011) Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice. Cancer Prev Res (Phila) 4(3):396-403. doi:10.1158/1940-6207.CAPR-10-03314/3/396[pii]
87. Wang ZY, Hong JY, Huang MT, Reuhl KR, Conney AH, Yang CS (1992) Inhibition of Nnitrosodiethylamine-and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res 52(7):1943-1947
88. Schuller HM, Porter B, Riechert A, Walker K, Schmoyer R (2004) Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokers. Lung Cancer 45(1):11-18. doi:10.1016/j.lungcan.2003.12.007
89. Lu YP, Lou YR, Lin Y, Shih WJ, Huang MT, Yang CS, Conney AH (2001) Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat. Cancer Res 61(13):5002-5009
90. Caporali A, Davalli P, Astancolle S, D’Arca D, Brausi M, Bettuzzi S, Corti A (2004) The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression. Carcinogenesis 25(11):2217-2224. doi:10.1093/carcin/bgh235
91. Sato D, Matsushima M (2003) Preventive effects of urinary bladder tumors induced by Nbutyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves. Int J Urol Official J Japan Urol Assoc 10(3):160-166
92. Sugamura K, Keaney JF Jr (2011) Reactive oxygen species in cardiovascular disease. Free Radic Biol Med 51(5):978-992. doi:10.1016/j.freeradbiomed.2011.05.004
93. Negishi H, Xu JW, Ikeda K, Njelekela M, Nara Y, Yamori Y (2004) Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J Nutr 134(1):38-42
94. Miura Y, Chiba T, Tomita I, Koizumi H, Miura S, Umegaki K, Hara Y, Ikeda M, Tomita T (2001) Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr 131(1):27-32
95. Hao J, Kim CH, Ha TS, Ahn HY (2007) Epigallocatechin-3 gallate prevents cardiac hypertrophy induced by pressure overload in rats. J Vet Sci 8(2):121-129
96. Piao CS, Kim DS, Ha KC, Kim HR, Chae HJ, Chae SW (2011) The Protective Effect of Epigallocatechin-3 Gallate on Ischemia/Reperfusion Injury in Isolated Rat Hearts: An ex vivo Approach. Korean J Physiol Pharm Official J Korean Physiol Soc Korean Soc Pharm 15(5):259-266. doi:10.4196/kjpp.2011.15.5.259
97. Sasaki T, Unno K, Tahara S, Shimada A, Chiba Y, Hoshino M, Kaneko T (2008) Age-related increase of superoxide generation in the brains of mammals and birds. Aging Cell 7(4):459-469. doi:10.1111/j.1474-9726.2008.00394.x
98. Unno K, Takabayashi F, Kishido T, Oku N (2004) Suppressive effect of green tea catechins on morphologic and functional regression of the brain in aged mice with accelerated senescence (SAMP10). Exp Gerontol 39(7):1027-1034. doi:10.1016/j.exger.2004.03.033
99. Unno K, Takabayashi F, Yoshida H, Choba D, Fukutomi R, Kikunaga N, Kishido T, Oku N, Hoshino M (2007) Daily consumption of green tea catechin delays memory regression in aged mice. Biogerontology 8(2):89-95. doi:10.1007/s10522-006-9036-8
100. Allen CL, Bayraktutan U (2009) Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke Official J Int Stroke Soc 4(6):461-470. doi:10.1111/j.1747-4949.2009.00387.x
101. Inanami O, Watanabe Y, Syuto B, Nakano M, Tsuji M, Kuwabara M (1998) Oral administration of (-)catechin protects against ischemia-reperfusion-induced neuronal death in the gerbil. Free Radical Res 29(4):359-365
102. Lee H, Bae JH, Lee SR (2004) Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils. J Neurosci Res 77(6):892-900. doi:10.1002/jnr.20193
103. Lee S, Suh S, Kim S (2000) Protective effects of the green tea polyphenol (-)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils. Neurosci Lett 287(3):191-194
104. Lee JW, Lee YK, Ban JO, Ha TY, Yun YP, Han SB, Oh KW, Hong JT (2009) Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice. J Nutr 139(10):1987-1993. doi:10.3945/jn.109.109785
105. Rauf A, Khan R, Raza M, Khan H, Pervez S, De Feo V, Maione F, Mascolo N (2015) Suppression of inflammatory response by chrysin, a flavone isolated from Potentilla evestita Th. Wolf. In silico predictive study on its mechanistic effect. Fitoterapia 103:129-135. doi:10.1016/j.fitote.2015.03.019
106. Weerawatanakorn M, Lee YL, Tsai CY, Lai CS, Wan X, Ho CT, Li S, Pan MH (2015) Protective effect of theaflavin-enriched black tea extracts against dimethylnitrosamine-induced liver fibrosis in rats. Food Funct 6(6):1832-1840. doi:10.1039/c5fo00126a
107. Sang S, Lambert JD, Ho CT, Yang CS (2011) The chemistry and biotransformation of tea constituents. Pharmacol Res 64(2):87-99. doi:10.1016/j.phrs.2011.02.007
108. Byun JK, Yoon BY, Jhun JY, Oh HJ, Kim EK, Min JK, Cho ML (2014) Epigallocatechin-3-gallate ameliorates both obesity and autoinflammatory arthritis aggravated by obesity by altering the balance among CD4 + T-cell subsets. Immunol Lett 157(1-2):51-59. doi:10.1016/j.imlet.2013.11.006
109. Okuda MH, Zemdegs JC, de Santana AA, Santamarina AB, Moreno MF, Hachul AC, dos Santos B, do Nascimento CM, Ribeiro EB, Oyama LM (2014) Green tea extract improves high fat diet-induced hypothalamic inflammation, without affecting the serotoninergic system. J Nutr Biochem 25(10):1084-1089. doi:10.1016/j.jnutbio.2014.05.012
110. Qin B, Polansky MM, Harry D, Anderson RA (2010) Green tea polyphenols improve cardiac muscle mRNA and protein levels of signal pathways related to insulin and lipid metabolism and inflammation in insulin-resistant rats. Mol Nutr Food Res 54(Suppl 1):S14-S23. doi:10.1002/mnfr.200900306
111. Afzal M, Safer AM, Menon M (2015) Green tea polyphenols and their potential role in health and disease. Inflammopharmacology 23(4):151-161. doi:10.1007/s10787-015-0236-1
112. Cabrera C, Artacho R, Gimenez R (2006) Beneficial effects of green tea-a review. J Am Coll Nutr 25(2):79-99
113. Hernandez Figueroa TT, Rodriguez-Rodriguez E, Sanchez-Muniz FJ (2004) The green tea, a good choice for cardiovascular disease prevention? Arch Latinoam Nutr 54(4):380-394
114. Yang CS, Hong J (2013) Prevention of chronic diseases by tea: possible mechanisms and human relevance. Annu Rev Nutr 33:161-181. doi:10.1146/annurev-nutr-071811-150717
115. Huang J, Wang Y, Xie Z, Zhou Y, Zhang Y, Wan X (2014) The anti-obesity effects of green tea in human intervention and basic molecular studies. Eur J Clin Nutr 68(10):1075-1087. doi:10.1038/ejcn.2014.143
116. Hursel R, Viechtbauer W, Westerterp-Plantenga MS (2009) The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes (Lond) 33(9):956-961. doi:10.1038/ijo.2009.135
117. Basu A, Sanchez K, Leyva MJ, Wu M, Betts NM, Aston CE, Lyons TJ (2010) Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr 29(1):31-40
118. Chantre P, Lairon D (2002) Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomed Int J Phytotherapy Phytopharmacology 9 (1):3-8. doi:10.1078/0944-7113-00078
119. Kovacs EM, Lejeune MP, Nijs I, Westerterp-Plantenga MS (2004) Effects of green tea on weight maintenance after body-weight loss. Br J Nutr 91(3):431-437. doi:10.1079/BJN20041061
120. Maki KC, Reeves MS, Farmer M, Yasunaga K, Matsuo N, Katsuragi Y, Komikado M, Tokimitsu I, Wilder D, Jones F, Blumberg JB, Cartwright Y (2009) Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J Nutr 139(2):264-270. doi:10.3945/jn.108.098293
121. Nagao T, Hase T, Tokimitsu I (2007) A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity 15(6):1473-1483. doi:10.1038/oby.2007.176
122. Iso H, Date C, Wakai K, Fukui M, Tamakoshi A, Group JS (2006) The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Inter Med 144 (8):554-562
123. Diepvens K, Kovacs EM, Nijs IM, Vogels N, Westerterp-Plantenga MS (2005) Effect of green tea on resting energy expenditure and substrate oxidation during weight loss in overweight females. Br J Nutr 94(6):1026-1034
124. Hill AM, Coates AM, Buckley JD, Ross R, Thielecke F, Howe PR (2007) Can EGCG reduce abdominal fat in obese subjects? J Am Coll Nutr 26(4):396S-402S
125. Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, Chou P (2008) Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 27(3):363-370. doi:10.1016/j.clnu.2008.03.007
126. Mielgo-Ayuso J, Barrenechea L, Alcorta P, Larrarte E, Margareto J, Labayen I (2014) Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial. Br J Nutr 111(7):1263-1271. doi:10.1017/S0007114513003784
127. Eckel RH, Krauss RM (1998) American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutr Committee Circ 97(21):2099-2100
128. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diab Care 24(4):683-689
129. Hartley L, Flowers N, Holmes J, Clarke A, Stranges S, Hooper L, Rees K (2013) Green and black tea for the primary prevention of cardiovascular disease. Cochrane Datab Syst Rev 6: CD009934. doi:10.1002/14651858.CD009934.pub2
130. Munir KM, Chandrasekaran S, Gao F, Quon MJ (2013) Mechanisms for food polyphenols to ameliorate insulin resistance and endothelial dysfunction: therapeutic implications for diabetes and its cardiovascular complications. Am J Physiol Endocrinol Metab 305(6): E679-E686. doi:10.1152/ajpendo.00377.2013
131. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I (2006) Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296(10):1255-1265. doi:10.1001/jama.296.10.1255
132. Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, Kondo T, Tamakoshi A, Group Js (2011) Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health 65(3):230-240. doi:10.1136/jech.2009.097311
133. Wang ZM, Zhou B, Wang YS, Gong QY, Wang QM, Yan JJ, Gao W, Wang LS (2011) Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr 93(3):506-515. doi:10.3945/ajcn.110.005363
134. Wierzejska R (2014) Tea and health—a review of the current state of knowledge. Przeglad Epidemiologiczny 68(3):501-506, 595-509
135. Alzheimer’s A (2015) 2015 Alzheimer’s disease facts and figures. Alzheimer’s Dement J Alzheimer’s Assoc 11(3):332-384
136. Halliwell B (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18(9):685-716
137. Kuriyama S, Hozawa A, Ohmori K, Shimazu T, Matsui T, Ebihara S, Awata S, Nagatomi R, Arai H, Tsuji I (2006) Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. Am J Clin Nutr 83(2):355-361
138. Kandinov B, Giladi N, Korczyn AD (2009) Smoking and tea consumption delay onset of Parkinson’s disease. Parkinsonism Relat Disord 15(1):41-46. doi:10.1016/j.parkreldis.2008.02.011
139. Mak JC (2012) Potential role of green tea catechins in various disease therapies: progress and promise. Clin Exp Pharmacol Physiol 39(3):265-273. doi:10.1111/j.1440-1681.2012.05673.x
140. Sun CL, Yuan JM, Koh WP, Yu MC (2006) Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 27(7):1301-1309. doi:10.1093/carcin/bgl024
141. Li N, Sun Z, Han C, Chen J (1999) The chemopreventive effects of tea on human oral precancerous mucosa lesions. In: Proceedings of the society for experimental biology and medicine society for experimental biology and medicine, vol 220, no 4, pp 218-224
142. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A (2006) Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 66(2):1234-1240
143. Choan E, Segal R, Jonker D, Malone S, Reaume N, Eapen L, Gallant V (2005) A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach. Urol Oncol 23(2):108-113. doi:10.1016/j.urolonc.2004.10.008
144. Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CY, Flynn PJ (2003) A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 97(6):1442-1446. doi:10.1002/cncr.11200
145. McLarty J, Bigelow RL, Smith M, Elmajian D, Ankem M, Cardelli JA (2009) Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res (Phila) 2(7):673-682. doi:10.1158/1940-6207.CAPR-08-01671940-6207.CAPR-08-0167[pii]
146. Shimizu M, Fukutomi Y, Ninomiya M, Nagura K, Kato T, Araki H, Suganuma M, Fujiki H, Moriwaki H (2008) Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prev 17(11):3020-3025
147. Stingl JC, Ettrich T, Muche R, Wiedom M, Brockmoller J, Seeringer A, Seufferlein T (2011) Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population. BMC Cancer 11:360. doi:10.1186/1471-2407-11-360
148. Lee MJ, Wang ZY, Li H, Chen L, Sun Y, Gobbo S, Balentine DA, Yang CS (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev 4(4):393-399
149. Yang F, de Villiers WJ, McClain CJ, Varilek GW (1998) Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr 128(12):2334-2340
150. Jimenez-Saenz M, Martinez-Sanchez Mdel C (2006) Acute hepatitis associated with the use of green tea infusions. J Hepatol 44(3):616-617 S0168-8278(05)00816-0 [pii]/j. jhep.2005.11.041